Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates

This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-system interactions. We cover the role of AI Daily Roundup and its application in various industries and daily lives.

AI Adoption Could Save Businesses $35,000 Every Year

Businesses are immensely benefiting from AI adoption. AI technologies and capabilities have enabled businesses to transform their operations and scope of revenue generation with an unmatched precision. In 2022, the global AI software industry will touch $62 billion, thanks to an enhanced adoption rate among businesses that see AI and other intelligent capabilities as a means to mature in changing economic landscape. A new report from Yell highlights on the growing potential of using AI in business. It has revealed the impressive time, money and effort savings companies around the world could stand to make with AI adoption. If done right, businesses can s********* $35000* every year– an absolute game-changer in the modern context of automation and financial stability.

AiThority.com to Attend The Character of AI – A Technology Ethics Conference (Virtual)

AiThority.com, a leading B2B Technology publication dedicated to emerging domains in AI, Cloud Computing, Data Science and IoT, will be attending the The Character of AI – A Technology Ethics Conference on 21 July 2022. The AI ethics conference is organized by the Santa Clara University and the Markkula Center for Applied Ethics. The day-long public conference will focus on one of the most widely-debated topic in AI — Ethics.

Moleculera Labs and General Genomics Form Strategic Alliance to Utilize Proprietary AI to Provide Personalized Medicine for Autoimmune Neuropsychiatric Disorders

Moleculera Labs, Inc. (Moleculera) and General Genomics, Inc. (GGI) announce the formation of a strategic alliance between the two companies. GGI will bring the power of multiple patent-pending healthcare machine learning (ML) and artificial intelligence (AI) innovations to direct individualized healthcare via their Curo46 Engine. Moleculera will contribute its knowledge and expertise in autoimmune neuropsychiatric disorders, along with one of the largest collections of patient data, utilizing Moleculera Labs’ Autoimmune Encephalopathy and Basal Ganglia Encephalitis Panel (AE/BGE) also known as the Cunningham Panel. This blood panel identifies levels of autoantibodies that attack the brain and central nervous system that are associated with certain neurologic, psychiatric, and behavioral disorders.

Fairtility Launches AI Academy to Demystify Use of Artificial Intelligence in Fertility Care

Fairtility, the transparent AI innovator powering in vitro fertilization (IVF) for improved outcomes, announced the launch of the AI Academy, a new educational platform that will host healthcare and technology experts to engage the IVF community in the conversation around the responsible adoption of AI innovation in IVF care.

Startek Expands Product Platform to Enhance Employee Experience for Stronger Customer Engagement

Startek, a global customer experience (CX) solutions provider, announced the launch of Startek Agent AI, a modular platform combining three AI-powered solutions designed to enhance employee experience (EX) and deliver a superior CX.

Omni-Channel Grocery Shoppers Key to Unlocking Additional Growth for Retailers, Data Analysis Finds

Symphony RetailAI, a leading provider of end-to-end, integrated AI-powered merchandising, marketing and supply chain solutions for retailers and CPG manufacturers, announced the findings of an analysis of nearly 600 million shopper transactions to determine the impact of today’s omni-channel grocery shopper. A key finding is that online household penetration now reaches 6.4%, up 60% from pre-pandemic levels, and households that shop both in-store and online are growing at a rate of 10% year-over-year.